AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children
Egg-allergic children who undergo egg oral immunotherapy and achieve sustained unresponsiveness eat more egg and have fewer symptoms five years later.
Egg-allergic children who undergo egg oral immunotherapy and achieve sustained unresponsiveness eat more egg and have fewer symptoms five years later.
Basophil assays confirmed a lack of basophil reactivity to PVX108 vs peanut extract.
A 4-food elimination diet plus proton pump inhibitor therapy was more effective than PPI therapy alone in children with eosinophilic esophagitis.
Patients with eosinophilic esophagitis may have concurrent peanut allergy.
The immune response to vaccinations is lower in children who are obese compared with nonobese children.
The implementation of a short acting beta-agonist reduction program was associated with more patients fulfilling an asthma medication ratio ≥0.5.
Children with asthma who received montelukast had no increased risk for neuropsychiatric disease compared with children who did not receive montelukast.
Patients who were actively treated with AR101 reported accidental exposure to peanut less often, had fewer associated adverse events, and required less rescue medication compared with placebo.
Quality of sleep significantly improved in patients with allergic rhinitis who were treated with the house dust mite sublingual immunotherapy tablet.
People who take gastric acid suppression agents have a high risk of requiring subsequent anti-allergy drugs.